Keywords: biotech, gets, boost, 2nd, qtr, approvals, good

US biotech gets boost in 2nd qtr from approvals, good trials and faster FDA

Article | 21 July 2003

Print This

For the US biotechnology sector, the second quarter of 2003 has been marked by a "cascade of high-potential product approvals, excellent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in